Stockscreener 앱 받기
10.52
7.35%
0.72
시간 외 거래:
10.58
0.06
+0.57%
전일 마감가:
$9.80
열려 있는:
$10.14
하루 거래량:
1.36M
Relative Volume:
1.57
시가총액:
$915.71M
수익:
-
순이익/손실:
$-106.81M
주가수익비율:
-3.1766
EPS:
-3.3117
순현금흐름:
$-8.40M
1주 성능:
+10.62%
1개월 성능:
-3.04%
6개월 성능:
+13.00%
1년 성능:
-26.02%
1일 변동 폭
$10.06
$10.65
1주일 범위
$9.13
$10.65
52주 변동 폭
$5.1501
$16.73
이뮤놈 Stock (IMNM) Company Profile
명칭
Immunome Inc
전화
610-321-3700
주소
18702 N. CREEK PARKWAY, BOTHELL
IMNM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
10.52 | 853.04M | 0 | -106.81M | -8.40M | -3.3117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
이뮤놈 Stock (IMNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-05 | 개시 | Craig Hallum | Buy |
| 2025-04-02 | 개시 | Lake Street | Buy |
| 2024-11-08 | 개시 | Stephens | Overweight |
| 2024-05-31 | 개시 | Piper Sandler | Overweight |
| 2024-04-30 | 개시 | JP Morgan | Overweight |
| 2024-04-15 | 개시 | Guggenheim | Buy |
| 2024-01-29 | 개시 | Leerink Partners | Outperform |
| 2023-12-19 | 개시 | Wedbush | Outperform |
| 2021-10-29 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
이뮤놈 주식(IMNM)의 최신 뉴스
Is Immunome Inc. benefiting from innovation trendsEarnings Overview Summary & Expert Verified Movement Alerts - خودرو بانک
Visual trend scoring systems applied to Immunome Inc.Market Activity Report & Technical Pattern Based Signals - Newser
Will Immunome Inc. price bounce be sustainableEntry Point & Expert Curated Trade Setup Alerts - Newser
Will earnings trigger a reversal in Immunome Inc.2025 Top Decliners & Technical Buy Zone Confirmations - Newser
Immunome (IMNM.O) Surges 5.66% — What’s Behind the Unusual Move? - AInvest
Best data tools to analyze Immunome Inc. stockMarket Volume Summary & Stock Portfolio Risk Management - Newser
Craig-Hallum Initiates Coverage on Immunome (IMNM) with 'Buy' Ra - GuruFocus
Using data models to predict Immunome Inc. stock movementJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - Newser
Immunome Stock Rises After Craig-Hellum Initiates Coverage With $26 Price Target: Here’s Why The Analyst Sees An ‘Attractive Entry Point’ - Asianet Newsable
When is the best time to exit Immunome Inc.Earnings Recap Summary & Growth Focused Stock Pick Reports - Newser
Using Bollinger Bands to evaluate Immunome Inc.July 2025 Pullbacks & Weekly High Return Opportunities - Newser
Is Immunome Inc. part of any ETF2025 Winners & Losers & Community Verified Swing Trade Signals - خودرو بانک
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 563 - GuruFocus
Using data filters to optimize entry into Immunome Inc.July 2025 Market Mood & AI Powered Market Entry Strategies - Newser
Is a relief rally coming for Immunome Inc. holdersJuly 2025 PostEarnings & Weekly High Return Opportunities - Newser
Can Immunome Inc. maintain its current growth rateWeekly Stock Analysis & Verified Swing Trading Watchlist - خودرو بانک
Risk vs reward if holding onto Immunome Inc.Trend Reversal & Expert Approved Momentum Ideas - Newser
Regression analysis insights on Immunome Inc. performanceJuly 2025 Outlook & Daily Chart Pattern Signals - Newser
Analyzing net buyer seller activity in Immunome Inc.2025 Top Decliners & Daily Growth Stock Investment Tips - Newser
Is Immunome Inc. trending in predictive chart modelsJuly 2025 Snapshot & Fast Moving Market Watchlists - Newser
Is Immunome Inc. a candidate for recovery playJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - Newser
Using Ichimoku Cloud for Immunome Inc. technicalsWeekly Trend Recap & Step-by-Step Swing Trade Plans - Newser
How does Immunome Inc. perform in inflationary periodsJuly 2025 Patterns & Fast Exit and Entry Trade Guides - khodrobank.com
Published on: 2025-09-03 09:01:24 - Newser
Iovance Biotherapeutics shares rise 1.32% premarket after Immunome's presentation at H.C. Wainwright conference. - AInvest
Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Yahoo Finance
Will Immunome Inc. continue its uptrendMarket Risk Report & AI Enhanced Execution Alerts - Newser
Why Immunome Inc. stock attracts strong analyst attention2025 Performance Recap & Step-by-Step Swing Trade Plans - Newser
Price momentum metrics for Immunome Inc. explainedMarket Risk Summary & Safe Swing Trade Setup Alerts - Newser
What is the long term forecast for Immunome Inc. stockMarket Performance Recap & High Conviction Trade Alerts - خودرو بانک
Immunome, Inc. (NASDAQ:IMNM) Given Average Recommendation of “Buy” by Analysts - Defense World
Can Traders Expect Breakout From Immunome Inc. This Week2025 Geopolitical Influence & AI Enhanced Market Trend Forecasts - beatles.ru
Will Immunome Inc. bounce back from current supportTrade Volume Report & Real-Time Volume Surge Alerts - Newser
Is Immunome Inc. building a consolidation baseInsider Buying & Daily Entry Point Trade Alerts - Newser
Analyzing recovery setups for Immunome Inc. investorsJobs Report & Daily Momentum Trading Reports - Newser
Nuveen LLC Takes Position in Immunome, Inc. $IMNM - Defense World
Trend Dashboard Flags Immunome Inc. As Potential Swing Trade getLinesFromResByArray error: size == 0 - sisaissue.com
Immunome Inc. Uptrend in Early Stages Indicators Say YesJuly 2025 Analyst Calls & Risk Managed Trade Strategies - beatles.ru
What Fibonacci levels say about Immunome Inc. rebound2025 Retail Activity & Safe Entry Point Alerts - Newser
Immunome Inc. Price Holds Above Key Fib Level getLinesFromResByArray error: size == 0 - 클래시안
이뮤놈 (IMNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
이뮤놈 주식 (IMNM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Higgins Jack | Chief Scientific Officer |
Mar 27 '25 |
Option Exercise |
1.35 |
5,200 |
7,020 |
18,729 |
| BIENAIME JEAN JACQUES | Director |
Mar 25 '25 |
Buy |
7.78 |
7,800 |
60,684 |
31,415 |
| SIEGALL CLAY B | President and CEO |
Mar 26 '25 |
Buy |
7.29 |
137,100 |
999,459 |
806,736 |
| BIENAIME JEAN JACQUES | Director |
Mar 24 '25 |
Buy |
8.21 |
7,000 |
57,470 |
23,615 |
| Tsai Philip | Chief Technology Officer |
Mar 24 '25 |
Buy |
8.42 |
12,300 |
103,566 |
33,300 |
| SIEGALL CLAY B | President and CEO |
Jan 31 '25 |
Buy |
7.75 |
150,000 |
1,162,500 |
669,636 |
| SIEGALL CLAY B | President and CEO |
Nov 21 '24 |
Buy |
9.54 |
66,057 |
630,263 |
485,693 |
| SIEGALL CLAY B | President and CEO |
Nov 22 '24 |
Buy |
9.78 |
33,943 |
331,918 |
519,636 |
| Lechleider Robert | Chief Medical Officer |
Nov 21 '24 |
Buy |
9.48 |
15,805 |
149,800 |
15,805 |
| Tsai Philip | Chief Technology Officer |
Nov 21 '24 |
Buy |
9.43 |
21,000 |
198,030 |
21,000 |
1.40%
자본화:
|
볼륨(24시간):